Delaware Chapter of the American College of CardiologyOur purpose is to contribute to the prevention of cardiovascular diseases, to ensure optimal quality of care for individuals with such diseases, and to foster the highest professional ethical standards. Please let us know what information you want to see here. Feel free to contact us with your ideas, needs and comments. |
|
ACC Live Courses For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings |
Latest in Cardiology from ACC.org
- Eagle’s Eye View: ACC/AHA Joint Perioperative Guidelines; Atenolol and MACE Risk; Yoga and VPCs; DECIPHER & CMRIn this week’s View, Dr. Eagle looks at how the most recent perioperative guideline published in 2024 remains valid and current.
- Racial, Ethnic and Place-Based Disparities in CVD Mortality in the USDespite sustained declines in overall cardiovascular disease mortality in the U.S., racial, ethnic and place-based disparities persist, with mortality varying far more across counties than states, according to a county-by-cause-by-population analysis published in JACC.
- Stellate Ganglion Block Reduces POAF After CABGPreemptive left stellate ganglion block (SGB) was associated with a reduced incidence of postoperative atrial fibrillation (POAF) within five postoperative days in patients undergoing CABG with cardiopulmonary bypass, according to results from a prospective controlled trial published Sept. 29 in JACC: Clinical Electrophysiology.
- OCTOBER Analysis: 1-Stent vs. 2-Stent PCI in True Bifurcation LesionsIn patients with true bifurcation lesions, clinical indication, left main coronary artery (LMCA) bifurcation and side branch (SB) disease severity were the strongest predictors of two-stent PCI, while optical coherence tomographic (OCT)-guided one-stent PCI was associated with the lowest risk for major adverse cardiovascular events...
- PCM GENES: Pediatric HCM, Severe LVH and Gene VariantsSevere left ventricular hypertrophy (LVH) was associated with younger age at enrollment and a higher likelihood of a pathogenic variant in MYBPC3 in children with hypertrophic cardiomyopathy (HCM), according to research published Sept. 24 in JACC: Heart Failure.



